×

Revolutionizing Balance Assessment with ICS® Dizcovery

ICS Dizcovery VNG

Introduction

The status quo in balance diagnostics isn’t enough. On average, it takes four to five specialists over five to seven years to diagnose the cause of a patient’s dizziness, vertigo, or balance issues. ICS® Dizcovery challenges these outdated statistics by offering the first-ever all-in-one videonystagmography (VNG) solution with plug-and-play goggles. By integrating VNG, video head impulse testing (vHIT), and caloric testing into a single diagnostic software platform, ICS Dizcovery enhances workflow efficiency, minimizes data errors, and delivers precise results faster than ever.

 

A Groundbreaking Approach to Balance Testing

ICS Dizcovery is designed to streamline balance assessments for ear, nose, and throat (ENT) specialists, audiologists, neurologists, and physical therapists. Traditional VNG systems often require fixed, earth-bound targets and rigid testing environments. ICS Dizcovery eliminates these constraints with:

  • Smart and Streamlined Hardware: Plug-and-play goggles that connect via USB, ensuring seamless setup and enhanced portability.
  • Freedom Laser™ Technology: An integrated moving visual target that removes the need for earth-fixed targets, reducing calibration errors.
  • Portable and Lightweight Design: At just 395 grams, the device is easy to transport and doesn’t require a dedicated testing location.
  • Highly Serviceable Construction: Designed for easy maintenance to minimize clinical interruptions.

 

Advanced Software for Unmatched Precision

ICS Dizcovery operates on the Otosuite® Vestibular platform, which unifies all necessary tests into one intuitive software. This module-based approach allows clinics to start with essential functions and expand as needed. Key benefits include:

  • Seamless Integration: Combines ICS Dizcovery, ICS® Impulse, and ICS® Aircal tests in a single platform.
  • Objective and Consistent Results: Automated sight obstruction panels improve tests like Skew Deviation, while Fit-2-Face™ and ShadeShift™ technologies ensure complete vision denial.
  • Real-Time Error Detection: Step-by-step guidance alerts users to errors, ensuring accurate data collection.
  • Advanced Interpretation Assistance: The software flags abnormal results and suggests potential causes, improving diagnostic confidence.

 

Breaking Down Data Silos

One of the most significant challenges in vestibular diagnostics is the fragmentation of data across different tests and platforms. ICS Dizcovery addresses this by:

  • Providing a Unified Diagnostic View: All test results are easily accessible and shareable among specialists.
  • Offering High-Definition Binocular Resolution: A frame rate of up to 200 fps ensures accurate eye-tracking and reliable data interpretation.
  • Reducing Workflow Friction: With integrated tools, healthcare professionals spend more time with patients and less time on technical complexities.

 

Clinical Impact and Future Applications

ICS Dizcovery sets a new benchmark in balance diagnostics, improving outcomes for:

  • Vestibular Disorders: Its high precision enhances the diagnosis of conditions like vestibular neuritis and Meniere’s disease.
  • Neurological Evaluations: Eye-tracking anomalies can indicate early-stage neurological disorders.
  • Pediatric and Geriatric Care: The system’s portability and ease of use makes it easier to treat diverse patient groups.

By challenging expectations and redefining balance assessment technology, ICS Dizcovery empowers clinicians with tools to make faster, more accurate diagnoses.

 

Conclusion

ICS Dizcovery is more than just a diagnostic tool—it’s a revolution in balance assessment. Its plug-and-play design, cutting-edge Freedom Laser™ technology, and seamless software integration make it the most advanced VNG solution available today. By minimizing diagnostic delays and enhancing clinical precision, ICS Dizcovery is transforming patient care and improving lives worldwide.

ICS Dizcovery VNG

Are you ready to challenge expectations and change outcomes? 

048610 RevA